| Primary |
| Acne |
57.8% |
| Contraception |
15.0% |
| Acne Cystic |
14.0% |
| Oral Contraception |
2.2% |
| Neuroblastoma |
1.2% |
| Drug Use For Unknown Indication |
1.1% |
| Anaemia |
0.9% |
| Depression |
0.8% |
| Pregnancy |
0.8% |
| Fungal Infection |
0.7% |
| Post Coital Contraception |
0.7% |
| Staphylococcal Infection |
0.7% |
| Glioblastoma |
0.6% |
| Sweat Gland Infection |
0.6% |
| Vomiting |
0.6% |
| Influenza |
0.5% |
| Medulloblastoma |
0.5% |
| Acne Conglobata |
0.4% |
| Brain Neoplasm Malignant |
0.4% |
| Hidradenitis |
0.4% |
|
| Unintended Pregnancy |
73.3% |
| Suicidal Ideation |
6.9% |
| Pregnancy |
3.3% |
| Drug Exposure During Pregnancy |
2.2% |
| Treatment Noncompliance |
2.0% |
| Suicide Attempt |
1.6% |
| Pregnancy Test False Positive |
1.3% |
| Depression |
1.3% |
| Abortion Spontaneous |
1.0% |
| Blood Triglycerides Increased |
0.9% |
| Headache |
0.8% |
| Exposure Via Semen |
0.7% |
| Mood Altered |
0.7% |
| Vomiting |
0.7% |
| Self-injurious Ideation |
0.7% |
| Maternal Exposure During Pregnancy |
0.6% |
| Arthralgia |
0.6% |
| Pregnancy On Oral Contraceptive |
0.6% |
| Paternal Drugs Affecting Foetus |
0.4% |
| Urinary Tract Infection |
0.4% |
|
| Secondary |
| Acne |
66.4% |
| Drug Use For Unknown Indication |
15.6% |
| Acne Cystic |
7.2% |
| Product Used For Unknown Indication |
2.7% |
| Contraception |
1.9% |
| Keratosis Follicular |
1.2% |
| Glioblastoma Multiforme |
1.1% |
| Scar |
0.9% |
| Depression |
0.5% |
| Sweat Gland Infection |
0.4% |
| Brain Neoplasm |
0.3% |
| Folliculitis |
0.3% |
| Asthma |
0.2% |
| Oral Contraception |
0.2% |
| Weight Decreased |
0.2% |
| Hypersensitivity |
0.2% |
| Rosacea |
0.2% |
| Blood Pressure Increased |
0.1% |
| Dermatitis Papillaris Capillitii |
0.1% |
| Hidradenitis |
0.1% |
|
| Inflammatory Bowel Disease |
23.1% |
| Pregnancy |
17.5% |
| Suicidal Ideation |
7.1% |
| Anxiety |
6.5% |
| Unintended Pregnancy |
6.5% |
| Blood Triglycerides Increased |
3.6% |
| Irritable Bowel Syndrome |
3.5% |
| Depression |
3.3% |
| Drug Exposure During Pregnancy |
3.3% |
| Rectal Haemorrhage |
3.3% |
| Lip Dry |
3.2% |
| Mood Altered |
3.0% |
| Arthralgia |
2.5% |
| Dry Eye |
2.2% |
| Stress |
2.2% |
| Treatment Noncompliance |
2.1% |
| Headache |
1.9% |
| Vaginal Haemorrhage |
1.9% |
| Xerosis |
1.7% |
| Colitis |
1.5% |
|
| Concomitant |
| Acne |
33.5% |
| Eczema |
14.0% |
| Contraception |
6.8% |
| Drug Use For Unknown Indication |
6.2% |
| Product Used For Unknown Indication |
6.2% |
| Asteatosis |
4.7% |
| Folliculitis |
4.7% |
| Lip Disorder |
4.7% |
| Cheilitis |
2.8% |
| Depression |
2.5% |
| Acne Cystic |
2.2% |
| Migraine |
2.2% |
| Muscle Spasms |
1.9% |
| Nasopharyngitis |
1.6% |
| Anxiety |
1.2% |
| Pain |
1.2% |
| Asthma |
0.9% |
| Dermatitis Papillaris Capillitii |
0.9% |
| Dry Eye |
0.9% |
| Menstruation Irregular |
0.9% |
|
| Vomiting |
27.0% |
| Pulmonary Embolism |
22.2% |
| Menstrual Disorder |
6.3% |
| Palpitations |
4.8% |
| Suicidal Ideation |
4.8% |
| Cholecystitis Chronic |
3.2% |
| Deep Vein Thrombosis |
3.2% |
| Emotional Distress |
3.2% |
| Injury |
3.2% |
| Pregnancy With Contraceptive Patch |
3.2% |
| Treatment Noncompliance |
3.2% |
| Unintended Pregnancy |
3.2% |
| Abdominal Discomfort |
1.6% |
| Anger |
1.6% |
| Anhedonia |
1.6% |
| Asteatosis |
1.6% |
| Chest Pain |
1.6% |
| Cholesterosis |
1.6% |
| Drug Exposure During Pregnancy |
1.6% |
| Eczema |
1.6% |
|
